| Product Code: ETC7662519 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel saw a consistent flow of specialty injectable generics imports, with top exporting countries including Switzerland, UK, Belgium, USA, and Germany. Despite this, market concentration, as measured by the HHI, remained low. The compound annual growth rate (CAGR) from 2020 to 2024 was at -2.14%, indicating a slight decline. Moreover, the growth rate from 2023 to 2024 was also negative at -0.41%, suggesting a challenging market environment for specialty injectable generics in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Specialty Injectable Generics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Specialty Injectable Generics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Specialty Injectable Generics Market - Industry Life Cycle |
3.4 Israel Specialty Injectable Generics Market - Porter's Five Forces |
3.5 Israel Specialty Injectable Generics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Specialty Injectable Generics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Specialty Injectable Generics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Specialty Injectable Generics Market Trends |
6 Israel Specialty Injectable Generics Market, By Types |
6.1 Israel Specialty Injectable Generics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Specialty Injectable Generics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Specialty Injectable Generics Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.4 Israel Specialty Injectable Generics Market Revenues & Volume, By Biologics, 2021- 2031F |
6.2 Israel Specialty Injectable Generics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Specialty Injectable Generics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Israel Specialty Injectable Generics Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.2.4 Israel Specialty Injectable Generics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.5 Israel Specialty Injectable Generics Market Revenues & Volume, By Central Nervous Systems, 2021- 2031F |
6.2.6 Israel Specialty Injectable Generics Market Revenues & Volume, By Autoimmune Disorders, 2021- 2031F |
6.2.7 Israel Specialty Injectable Generics Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Specialty Injectable Generics Market Import-Export Trade Statistics |
7.1 Israel Specialty Injectable Generics Market Export to Major Countries |
7.2 Israel Specialty Injectable Generics Market Imports from Major Countries |
8 Israel Specialty Injectable Generics Market Key Performance Indicators |
9 Israel Specialty Injectable Generics Market - Opportunity Assessment |
9.1 Israel Specialty Injectable Generics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Specialty Injectable Generics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Specialty Injectable Generics Market - Competitive Landscape |
10.1 Israel Specialty Injectable Generics Market Revenue Share, By Companies, 2024 |
10.2 Israel Specialty Injectable Generics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |